Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Predicant Names Richard Bastiani to Board of Directors.


SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif. -- Predicant predicant
Adjective

of preaching

Noun

a member of a religious order founded for preaching, usually a Dominican [Latin praedicans preaching]
 Biosciences today announced the appointment of Richard Bastiani, Ph.D., to the company's board of directors.

An experienced senior executive in the life sciences industry, Dr. Bastiani brings to Predicant both operational expertise in developing and commercializing innovative technology, as well as a track record of building new and successful businesses.

Dr. Bastiani currently is chairman of ID Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
, a human vaccine company. He also serves on the board of Abaxis, which specializes in point-of-care diagnostics, and is a director and co-founder of DiscoverRx, which is focused on high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method  and proteomics products for pharmaceutical drug discovery.

Dr. Bastiani previously was president of Dendreon, a biotechnology company developing cell-based therapies for treatment of cancer. Earlier in his career, Dr. Bastiani served as president of Syva Company, a global clinical diagnostics company.

"Richard's experience in the diagnostics, proteomics and oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors.

on·col·o·gy
n.
 arenas will be an invaluable asset for Predicant," said Deborah J. Neff, Predicant's chief executive officer. "His insight will be especially helpful at this stage in our product development and as we begin to build a market for our novel diagnostics based on protein-pattern analysis."

About Predicant (www.predicant.com)

Predicant is an emerging life sciences company focused on developing tests to detect and diagnose diagnose /di·ag·nose/ (di´ag-nos) to identify or recognize a disease.

di·ag·nose
v.
1. To distinguish or identify a disease by diagnosis.

2.
 disease through the analysis of complex protein patterns in blood. Predicant believes that this approach, which is based on major scientific research supporting the utility of protein biomarkers, will offer better diagnostic and prognostic prog·nos·tic
adj.
1. Of, relating to, or useful in prognosis.

2. Of or relating to prediction; predictive.

n.
1. A sign or symptom indicating the future course of a disease.

2.
 accuracy than can be achieved with current proteomics approaches. Predicant's method uses proprietary, integrated technology, which is designed to produce the high quality, reproducible results necessary for reliable clinical use. Predicant's technology has broad potential application, including early disease detection, monitoring disease progression and predicting the effectiveness of therapy, as well as aiding in pharmaceutical research.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 4, 2004
Words:299
Previous Article:ZOLL Medical Corporation Fourth Quarter Earnings Conference Call Notification.
Next Article:URS and DuPont Extend Alliance; Five-Year Contract Has Maximum Value of $80 Million to URS.



Related Articles
RBX appoints Roland president/CEO.
The board of directors of Columbian Chemicals named John T. Walsh president.
Witco's board of directors confirmed the appointment of Camillo J. DiFrancesco as chief financial officer.
Taras Konowal as named president of Bucher.
Jeffrey B. Miller was appointed president of Spectra, a Markem subsidiary.
FOWLER, DISTINGUISHED EDITOR.
Brett White takes over the reins at CB Richard Ellis.
Former U.S. Senator Tom Daschle joins CBRE board.
Bedside manner: Philips, already a giant in consumer electronics, bets on healthcare in Latin America for growth.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles